Can Fite BioPharma Ltd (CANF)

[midastouch017]

Can-Fite BioPharma (CANF) Receives a Buy from H.C. Wainwright

April 06 2022 - 06:25AM
TipRanks

In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Can-Fite BioPharma (CANF – Research Report), with a price target of $5.00. The company's shares closed last Tuesday at $1.24. According to TipRanks.com, Bernardino is a 5-star analyst with an average return of 27.9% and a 38.0% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Eledon Pharmaceuticals, Citius Pharmaceuticals, and Aridis Pharmaceuticals. Can-Fite BioPharma has an analyst consensus of Moderate Buy, with a price target consensus of $7.00, implying a 455.6% upside from current levels.
https://www.tipranks.com/news/blurbs/can-fite-biopharma-canf-receives-a-buy-from-h-c-wainwright-2?utm_source=advfn.com&utm_medium=referral